Inactive Instrument

Neovasc Inc (US) Stock Nasdaq

Equities

Duration

Period

Style

The European Society of Cardiology Includes Neovasc Reducer™ for the Treatment of Refractory Angina in the European Practice Guidelines for the Diagnosis and Management of Chronic Coronary Syndromes	19-09-03	GL
Neovasc US : Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency	19-01-14	PU

Sector